Uncertificated Securities Market
Introduction
Our participation in the Uncertificated Securities Market
Beijing Sinotau International Pharmaceutical Technology Co., Ltd. (the “Company”) will participate in Hong Kong’s Uncertificated Securities Market (“USM”).
From November 24, 2026, the Company’s shares [09941.HK] will become participating securities under USM. Investors will have an option for holding and managing their securities digitally.
The Company has appointed Computershare Hong Kong Investor Services Limited (“Computershare”) as its Approved Securities Registrar (“ASR”). Computershare will operate the USI facility through which registered shareholders may hold and manage the Company’s securities in uncertificated form in their own names.
Key dates
|
Milestone |
Date |
|
USM Participation Date |
November 24, 2026 |
|
First day for submitting different requests, including |
|
|
- A request to transfer securities in uncertificated form via USI facility or HKSCC |
November 24, 2026 |
What USM means for shareholders
Under USM, registered shareholders may hold the Company’s securities digitally in uncertificated form in their own names.
Shareholders holding securities in uncertificated form will continue to enjoy the rights attached to their securities as registered shareholders.
At a glance
- Issue new securities only in uncertificated form on or after 16 November 2026. No physical certificates will be issued.
- New securities acquired and registered in a shareholder’s own name on or after Listing Date must be held in uncertificated form.
- Uncertificated holdings cannot subsequently be converted back into certificated holdings.
Your holding options
1. Hold securities electronically in your own name
From the Listing Date, you may choose to hold the Company’s securities digitally in uncertificated form in your own name.
To do this, you will need to set up a USI profile with Computershare, and provide your USI identifier in your White Form eIPO application.
If an investor without a USI profile receives new uncertificated securities, they will have the status of provisional system member. While such holders will have full rights for such securities (e.g., when voting or receiving dividends), they will need to apply for a USI profile with Computershare before they can transfer, or receive transfers of uncertificated securities.
2. Hold securities in uncertificated form through an intermediary
If you hold the Company’s securities through an intermediary and are interested in becoming an uncertificated holder after the Participation Date, you should establish a USI profile and instruct your intermediary to transfer the securities to your USI profile in uncertificated form.
Setting up a USI profile
By setting up a USI profile with Computershare, a registered shareholder can use the USI Facility (Investor Centre Hong Kong platform) to hold and manage uncertificated securities electronically in their own name.
Shareholders wishing to use the platform must complete the USI profile opening procedures with Computershare and satisfy its identity verification and supporting document requirements.
Please visit the landing page of Computershare’s Investor Centre for information about:
• setting up a USI profile;
• applicable identity and supporting-document requirements;
• managing uncertificated holdings; and
• available service channels.
Transfers after the Participation Date
No new physical certificates for the Company’s participating securities will be issued on or after the Company’s Participation Date.
If you acquire securities on or after that date and wish to register them in your own name, you must establish a USI profile, and the securities must be held in uncertificated form.
For information about transferring uncertificated securities, please refer to Computershare’s Investor Centre.
Corporate actions and new securities
After the Company’s securities become participating securities, securities or entitlements arising from certain corporate actions must be issued in uncertificated form only.
These corporate actions may include:
- rights issues;
- bonus issues;
- scrip dividends; and
- other actions involving the issue of securities.
If a registered shareholder has not set up a USI profile, the relevant new securities or entitlements may be recorded under provisional arrangements applicable to a provisional system-member.
Until the shareholder has established a USI profile and completed the applicable requirements, the shareholder may not be able to view, manage, transfer or otherwise deal with those securities, or exercise the relevant entitlements through the USI Facility by the applicable deadline.
The Company will provide specific information about the applicable arrangements and any action required from shareholders when announcing a relevant corporate action.
Fees and processing arrangements
Fees and charges may apply to services including:
- setting up or maintaining a USI Facility. Visit Computershare’s site for info on current charges (if any)
- dematerialising certificated securities ($5 per title instrument, with a minimum of $20 (limit only applicable to individuals);
- registering transfers of uncertificated securities (0.02% of transaction value, with a minimum of $20. No fee to be charged by ASRs for withdrawals from HKSCC Nominees); and
- other shareholder requests or services.
The applicable procedures, processing times and fees are determined by Computershare and may vary depending on the service requested.
View Computershare’s fees and charges
Important documents and links
Contact us
If you have questions about the Company’s USM participation plan or the action you may need to take, please contact:
Computershare Hong Kong Investor Services Limited
Address:17M floor/17 floor shops 1712-16, Hopewell Centre, 183 Queen’s Road East, Wan Chai
Hotline: +852 2862 8555
Website: www.computershare.com
For enquiries relating specifically to the Company:
Beijing Sinotau International Pharmaceutical Technology Co., Ltd.
Email: ir@sinotau.com
Terms otherwise in documents of title
北京先通國際醫藥科技股份有限公司 Beijing Sinotau International Pharmaceutical Technology Co., Ltd. (“the company”) was established on 24th January 2005 in the People’s Republic of China (the “PRC”) in accordance with the Company Law (as defined below) and other relevant PRC laws and administrative regulations with business licence number 9111010677157669X2.
The registered share capital of the company is divided into domestic shares of nominal value RMB1.00 each (“Domestic Shares”), and overseas listed foreign invested shares of nominal value RMB1.00 each (“H Shares”), each of the Domestic Shares and H Shares carries the same voting rights at general meetings of the company.
Code:09941.HK
- The company’s legal address: Floors 1-2, Block 1, No. 5, Tongji Road Central, Beijing Economic-Technological Development Area, Beijing, PRC
- H Share Registrar: Computershare Hong Kong Investor Services Limited, Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong
By acquiring the H Shares of the company, the registered holder(s) of the H Share(s) stated above:
(i)agree(s) with the company and each other shareholder of the company, and the company agrees with such registered holder(s) and each other shareholder of the company, to observe and comply with the Company Law of the PRC (《中華人民共和國公司法》), adopted by the Standing Committee of the Eighth National People's Congress on 29th December, 1993 and effective from 1st July, 1994, as amended, supplemented or otherwise modified from time to time (the "Company Law”), the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies (《境內企業境外發行證券和上市管理試行辦法》) promulgated by the China Securities Regulatory Commission (中國證券監督管理委員會) on 17th February 2023, as amended, supplemented or otherwise modified from time to time and the Articles of Association and other relevant PRC laws and administrative regulations (as amended from time to time);
(ii)agree(s) with the company, each other shareholder, director, manager and officer of the company, and the company, acting for itself and for each director, manager and officer of the company, agree(s) with each shareholder of the company to refer all differences and claims arising from the Articles of Association or any rights or obligations conferred or imposed by the Company Law or other relevant laws and administrative regulations concerning the affairs of the company to arbitration in accordance with the Articles of Association, and any reference to arbitration shall be deemed to authorise the arbitration tribunal to conduct hearings in open session and to publish its award, and such arbitration shall be final and conclusive;
(iii)agree(s) with the company and each other shareholder of the company that H Shares in the registered capital of the company are freely transferable by the registered holder(s) thereof; and
(iv)authorise(s) the company to enter into a contract on his (their) behalf with each director, manager and officer of the company whereby such directors, managers and officers of the company undertake to observe and comply with their obligations to the shareholders of the company as stipulated in the Articles of Association.
Additional Computershare’ s resources
| Introduction of Computershare’s USI facility (Investor Centre) | |||
|
Download Investor Centre |
|||
|
User guide of Investor Centre |
|||
|
FAQ for Investor Centre |
|||
|
FAQ for USM |
|||
|
Fraud prevention tips |